Thermo Fisher Scientific Inc (NYSE:TMO)
| 514.66 BATS BZX Real-Time Price As of 9:33am ET |  -1.60 / -0.31%Today’s Change | 475.77 Today|||52-Week Range 611.06 | -6.54% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | 2.0B | 2.0B | 2.2B | 2.9B | |
| Depreciation | 1.7B | 1.8B | 2.0B | 2.3B | ||
| Total Other Cash Flow | 110.1M | 219.8M | 348.0M | 287.0M | ||
| Funds From Operations | 3.3B | 3.4B | 3.5B | 5.1B | ||
| Funds From/For Other Operating Expenses | 436.9M | 226.8M | -494.0M | 570.0M | ||
| Net Cash Flow - Operating Activities | 2.8B | 3.2B | 4.0B | 4.5B | ||
| Investing | Increase In Investments | 0.00 | -1.5M | -- | -- | |
| Decrease In Investments | 17.8M | 81.2M | 22.0M | 0.00 | ||
| Capital Expenditures | -422.9M | -444.4M | -508.0M | -758.0M | ||
| Fixed Asset Disposal | 18.1M | 26.3M | 7.0M | 50.0M | ||
| Net Assets From Acquisitions | -694.6M | -5.2B | -7.2B | -536.0M | ||
| Other Investing - Uses | -5.8M | -5.3M | -24.0M | -9.0M | ||
| Net Cash Flow Investing | -1.1B | -5.5B | -7.7B | -1.3B | ||
| Financing | Short Term Borrowings | 49.5M | 904.1M | -134.0M | -194.0M | |
| Long Term Borrowings | 1.8B | 7.6B | 6.5B | 690.0M | ||
| Long Term Debt Reduction | -3.8B | -4.3B | -3.3B | -2.1B | ||
| Net Proceeds Stock Sale | 124.0M | 135.3M | 1.8B | 136.0M | ||
| Common Preferred Redeemed | -500.0M | -1.3B | -750.0M | -500.0M | ||
| Common Dividends | -240.6M | -238.4M | -237.0M | -266.0M | ||
| Cash Dividends Paid - Total | -240.6M | -238.4M | -237.0M | -266.0M | ||
| Other Sources - Financing | 64.1M | 53.5M | 0.00 | 0.00 | ||
| Other Uses - Financing | 6.1M | 13.7M | 3.0M | 51.0M | ||
| Net Cash Flow - Financing | -2.5B | 2.9B | 3.9B | -2.2B | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -129.6M | -150.7M | 420.0M | -297.0M | |
| Net Change In Cash | -761.8M | 484.8M | 130.0M | 1.1B | ||
